Laurion Capital Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-670	Closed	-$326K	–	526
2025 Q4	$326K	Buy	+670	New	+$312K	0.02%	274
2024 Q3	–	Sell	-854	Closed	-$272K	–	616
2024 Q2	$272K	Buy	+854	New	+$226K	0.01%	445
2020 Q3	–	Sell	-2,142	Closed	-$259K	–	1195
2020 Q2	$259K	Buy	+2,142	New	+$241K	0.01%	747
2020 Q1	–	Sell	-20,100	Closed	-$1.77M	–	1169
2019 Q4	$1.77M	Buy	+20,100	New	+$1.77M	0.08%	481
2018 Q3	–	Sell	-3,332	Closed	-$377K	–	1583
2018 Q2	$377K	Buy	3,332 +1,540	+86%	+$169K	0.01%	1032
2018 Q1	$201K	Sell	1,792 -11,200	-86%	-$1.42M	﹤0.01%	1231
2017 Q4	$1.92M	Buy	12,992 +1,400	+12%	+$178K	0.03%	789
2017 Q3	$1.36M	Sell	11,592 -145,151	-93%	-$18.5M	0.03%	877
2017 Q2	$20.3M	Buy	156,743 +23,700	+18%	+$2.96M	0.45%	176
2017 Q1	$18M	Buy	+133,043	New	+$20.2M	0.51%	187
2016 Q4	–	Sell	-6,900	Closed	-$815K	–	1384
2016 Q3	$815K	Buy	+6,900	New	+$829K	0.03%	597